The Shroom Boom and other Therapeutic Psychedelics for the Win

 

We need to look out of the box for solutions to the problems of mental health.

Rachel Yehuda Trauma researcher and professor at Mount Sinai Icahn School of Medicin...
Session

The Shroom Boom and other Therapeutic Psychedelics for the Win

Setup

Mental-health and substance-use disorders — arguably more prevalent than ever during the pandemic ­— are a leading cause of disability globally. So it’s no wonder the clinical use of psychedelic drugs to help treat psychiatric disorders, including anxiety, depression, and PTSD, is fueling a research renaissance. Even Wall Street is taking notice: Three psychedelic drug developers have gone public in the last several months. Two leaders at the forefront of the field shed light on the science of psilocybin, MDMA, and ketamine and their use in psychedelic-assisted psychotherapy.

Explore More

Health

363 ideas
Sorry, we couldn't find any results
Clear filters
The Shroom Boom and other Therapeutic Psychedelics for the Win

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
Newsletter
Newsletter
Sign up to our newsletter
for the latest festival updates.